Positron emission tomography molecular imaging-based cancer phenotyping

被引：21
|
作者：
Jin, Chentao [1 ,2 ,3 ,4 ]
Luo, Xiaoyun [1 ,2 ,3 ,4 ]
Li, Xiaoyi [1 ,2 ,3 ,4 ]
Zhou, Rui [1 ,2 ,3 ,4 ]
Zhong, Yan [1 ,2 ,3 ,4 ]
Xu, Zhoujiao [1 ,2 ,3 ,4 ]
Cui, Chunyi [1 ,2 ,3 ,4 ]
Xing, Xiaoqing [1 ,2 ,3 ,4 ]
Zhang, Hong [1 ,2 ,3 ,4 ,5 ,6 ]
Tian, Mei [1 ,2 ,3 ,4 ]
机构：
[1] Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Positron Emiss Tomog Ctr, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ, Inst Nucl Med & Mol Imaging, Hangzhou, Peoples R China
[4] Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou, Peoples R China
[5] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Peoples R China
[6] Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China
来源：
CANCER | 2022年 / 128卷 / 14期
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
biomarker; cancer; cancer hallmarks; molecular imaging; positron emission tomography (PET); translational medicine; TUMOR-ASSOCIATED MACROPHAGES; PROSTATE-CANCER; BREAST-CANCER; AMINO-ACIDS; PET; EXPRESSION; VISUALIZATION; REPORTER; RECEPTOR; INFLAMMATION;
D O I：
10.1002/cncr.34228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
During the past several decades, numerous studies have provided insights into biological characteristics of cancer cells and identified various hallmarks of cancer acquired in the tumorigenic processes. However, it is still challenging to image these distinctive traits of cancer to facilitate the management of patients in clinical settings. The rapidly evolving field of positron emission tomography (PET) imaging has provided opportunities to investigate cancer's biological characteristics in vivo. This article reviews the current status of PET imaging on characterizing hallmarks of cancer and discusses the future directions of PET imaging strategies facilitating in vivo cancer phenotyping.
引用
收藏
页码：2704 / 2716
页数：13
相关论文
共 50 条
  • [1] Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma
    Zhang, Xiaohui
    Jiang, Han
    Wu, Shuang
    Wang, Jing
    Zhou, Rui
    He, Xuexin
    Qian, Shufang
    Zhao, Shuilin
    Zhang, Hong
    Civelek, Ali Cahid
    Tian, Mei
    PHENOMICS, 2022, 2 (02): : 102 - 118
  • [2] Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma
    Xiaohui Zhang
    Han Jiang
    Shuang Wu
    Jing Wang
    Rui Zhou
    Xuexin He
    Shufang Qian
    Shuilin Zhao
    Hong Zhang
    Ali Cahid Civelek
    Mei Tian
    Phenomics, 2022, 2 : 102 - 118
  • [3] Molecular imaging of cancer with positron emission tomography
    Gambhir, SS
    NATURE REVIEWS CANCER, 2002, 2 (09) : 683 - 693
  • [4] Molecular imaging of cancer with positron emission tomography
    Sanjiv Sam Gambhir
    Nature Reviews Cancer, 2002, 2 : 683 - 693
  • [5] Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient
    Franc, Benjamin L.
    Hawkins, Randall A.
    SEMINARS IN ROENTGENOLOGY, 2007, 42 (04) : 265 - 279
  • [6] Molecular imaging with positron emission tomography
    Phelps, ME
    ANNUAL REVIEW OF NUCLEAR AND PARTICLE SCIENCE, 2002, 52 : 303 - 338
  • [7] Positron emission tomography and molecular imaging
    Knuuti, J.
    Bengel, F. M.
    HEART, 2008, 94 (03) : 360 - 367
  • [8] Molecular Imaging Using Positron Emission Tomography in Colorectal Cancer
    Lin, Michael
    DISCOVERY MEDICINE, 2011, 11 (60) : 435 - 447
  • [9] Clinical molecular imaging with positron emission tomography
    Salem, Azeem
    Charnley, Natalie
    Price, Pat
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) : 1720 - 1727
  • [10] Positron Emission Tomography Imaging of Macrophages in Cancer
    Parker, Candace C.
    Lapi, Suzanne E.
    CANCERS, 2021, 13 (08)
12345